NASDAQ:UG - United-Guardian Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$17.29 -0.22 (-1.26 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$17.29
Today's Range$17.19 - $17.64
52-Week Range$15.51 - $20.33
Volume3,130 shs
Average Volume7,379 shs
Market Capitalization$80.45 million
P/E Ratio16.84
Dividend Yield6.28%
Beta-0.17
United-Guardian, Inc. manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products, and specialty industrial products in the United States and internationally. It offers personal care products, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL II XD; ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics; LUBRASLIDE and B-122 powdered lubricants for use in the manufacture of pressed powders, eyeliners, and rouges; KLENSOFT, a surfactant for use in shampoos, shower gels, makeup removers, and other cosmetic formulations; and LUBRASIL, a special form of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base. The company's medical products comprise LUBRAJEL RR and RC lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC, LUBRAJEL FA, and LUBRAJEL BA, which are LUBRAJEL formulations for oral use; LUBRAJEL FLUID to lubricate water-soluble products; and LUBRAJEL TF, a medical lubricant. Its pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder. The company's industrial products include DESELEX liquid, a sequestering and chelating agent for use in the manufacture of detergents; and THOROCLENS, a chlorine-based cleanser. United-Guardian, Inc. also conducts research and product development, primarily related to the development of cosmetic and personal care products. The company markets its products through marketing partners and distributors, advertising in medical and trade journals, mailings to physicians and to the trade, and exhibitions at medical meetings. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

Receive UG News and Ratings via Email

Sign-up to receive the latest news and ratings for UG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Toilet preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:UG
Previous Symbol
CUSIPN/A
Phone631-273-0900

Debt

Debt-to-Equity RatioN/A
Current Ratio10.59
Quick Ratio9.42

Price-To-Earnings

Trailing P/E Ratio16.84
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$12.97 million
Price / Sales6.12
Cash Flow$0.8693 per share
Price / Cash Flow19.89
Book Value$2.48 per share
Price / Book6.97

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$3.84 million
Net Margins33.88%
Return on Equity39.67%
Return on Assets34.93%

Miscellaneous

Employees31
Outstanding Shares4,590,000
Market Cap$80.45 million
OptionableNot Optionable

United-Guardian (NASDAQ:UG) Frequently Asked Questions

What is United-Guardian's stock symbol?

United-Guardian trades on the NASDAQ under the ticker symbol "UG."

How often does United-Guardian pay dividends? What is the dividend yield for United-Guardian?

United-Guardian announced a semiannual dividend on Friday, November 30th. Investors of record on Monday, December 10th will be paid a dividend of $0.55 per share on Monday, December 17th. This represents a dividend yield of 6.27%. The ex-dividend date of this dividend is Friday, December 7th. This is a positive change from United-Guardian's previous semiannual dividend of $0.50. View United-Guardian's Dividend History.

How were United-Guardian's earnings last quarter?

United-Guardian, Inc. (NASDAQ:UG) released its earnings results on Thursday, November, 9th. The company reported $0.24 earnings per share for the quarter. The firm had revenue of $3.18 million for the quarter. United-Guardian had a net margin of 33.88% and a return on equity of 39.67%. View United-Guardian's Earnings History.

When is United-Guardian's next earnings date?

United-Guardian is scheduled to release their next quarterly earnings announcement on Thursday, March 28th 2019. View Earnings Estimates for United-Guardian.

Has United-Guardian been receiving favorable news coverage?

Media stories about UG stock have been trending somewhat positive on Saturday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. United-Guardian earned a coverage optimism score of 0.7 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the next few days.

Who are some of United-Guardian's key competitors?

Who are United-Guardian's key executives?

United-Guardian's management team includes the folowing people:
  • Mr. Kenneth H. Globus, Pres, Chairman, Principal Exec. Officer & Gen. Counsel (Age 66)
  • Mr. Robert S. Rubinger, Exec. VP, Sec. & Director (Age 75)
  • Mr. Peter A. Hiltunen, VP & Production Mang. (Age 59)
  • Andrea J. Young, Chief Financial Officer, Treasurer & Controller (Age 49)
  • Donna Vigilante, R&D Mang. and Director of Technical Services

Who are United-Guardian's major shareholders?

United-Guardian's stock is owned by many different of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (5.27%) and Quantum Capital Management (1.07%). View Institutional Ownership Trends for United-Guardian.

Which institutional investors are buying United-Guardian stock?

UG stock was purchased by a variety of institutional investors in the last quarter, including Quantum Capital Management and Renaissance Technologies LLC. View Insider Buying and Selling for United-Guardian.

How do I buy shares of United-Guardian?

Shares of UG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is United-Guardian's stock price today?

One share of UG stock can currently be purchased for approximately $17.29.

How big of a company is United-Guardian?

United-Guardian has a market capitalization of $80.45 million and generates $12.97 million in revenue each year. United-Guardian employs 31 workers across the globe.

What is United-Guardian's official website?

The official website for United-Guardian is http://www.u-g.com.

How can I contact United-Guardian?

United-Guardian's mailing address is 230 MARCUS BOULEVARD, HAUPPAUGE NY, 11788. The company can be reached via phone at 631-273-0900.


MarketBeat Community Rating for United-Guardian (NASDAQ UG)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  57 (Vote Outperform)
Underperform Votes:  88 (Vote Underperform)
Total Votes:  145
MarketBeat's community ratings are surveys of what our community members think about United-Guardian and other stocks. Vote "Outperform" if you believe UG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel